Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$277,901
-$239,928 QoQ
Shares Held
4,823
-43.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,930
of 2,514 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. BMY ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
4,823 | $277,901 |
All Filings in BMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,901 | 4,823 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $517,829 | 8,538 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $465,717 | 8,634 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $364,768 | 8,088 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $366,153 | 7,910 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||